The global RNAi Pesticides Market size was valued at USD 68 million in 2025 and is estimated at USD 82 million in 2026, forecast to reach USD 342 million by 2035, expanding at a 17.5% CAGR from 2026 to 2035. Key drivers include expanding regulatory approvals for sprayable RNAi active ingredients and rising pest resistance to conventional chemical pesticides, supported by regulatory precedents for foliar-applied RNAi biopesticides and increasing adoption of RNAi as a complementary resistance management tool, with North America leading the global market.
At Next Move Strategy Consulting, we understand that insightful market research is the cornerstone of successful business decisions. That's why we employ a robust and multifaceted approach, combining various methodologies to deliver the most accurate and actionable data for our clients.
Research Landscape
We navigate the world of research with two primary approaches:
Our qualitative research methodologies involve immersive techniques such as in-depth interviews, focus groups, and observational studies. By engaging directly with individuals and stakeholders, we uncover valuable insights that quantitative data alone may overlook.
Quantitative Research
In tandem with qualitative methodologies, NMSC leverages the power of Quantitative Research to provide a robust foundation of numerical insights. Through systematic data collection and analysis, we quantify patterns, preferences, and market trends, offering a comprehensive view of the business landscape.
Our quantitative research approach employs diverse tools, including surveys, experiments, and statistical modelling. These methodologies enable us to gather data from a large and representative sample, ensuring the statistical significance of our findings. By employing structured questionnaires and standardized data collection methods, we guarantee the reliability and validity of the information we present to our clients.
Quantitative research is particularly effective in measuring the prevalence of trends, assessing market size, and gauging the impact of various factors on consumer behavior. The numerical precision attained through this approach equips our clients with actionable insights, facilitating data-driven decision-making and strategy formulation.
We deploy a specialized arsenal of techniques tailored to meet your unique requirements. Here's a glimpse into our comprehensive toolbox:
The stage entails acquiring market data or relevant information through various sources and methodologies.
We utilize both top-down and bottom-up approaches in market research analysis to achieve a comprehensive understanding of the market dynamics, leveraging the broad perspective of industry trends and macroeconomic factors alongside detailed insights from specific segments and individual companies.
We conduct Porter's Five Forces analysis to evaluate the competitive landscape of an industry, providing us with insights into factors that affect profitability and strategic positioning.
We utilize a forecasting model to predict future consumption by considering parameters like population, economics, regulations, market competition, drivers, constraints, technology, and pricing. We also employ statistical techniques such as multilinear regression, exponential smoothing, moving average, ARIMA, and Monte Carlo simulations for accurate predictions. In econometric forecasting, we analyzed short-term and long-term event impacts, attributing values based on regulatory frameworks, economic factors, and market events.
The global RNAi pesticides market size was valued at USD 68 million in 2025 and is estimated at USD 82 million in 2026, forecast to reach USD 342 million by 2035, expanding at a 17.5% CAGR between 2026 and 2035. North America leads with approximately 44% share, while dsRNA-Based Pesticides dominate all other product types with approximately 82% share.
We observed that the growth is broad-based across every segmentation axis, with expanding regulatory approvals and scalable dsRNA production platforms driving the dominant structural shifts through 2035.
Values in USD Million
By Product Type: dsRNA-Based Pesticides held the largest share of approximately 82% (USD 55.76 million) in 2025; siRNA-Based Pesticides is the fastest-growing sub-segment at 27.9% CAGR from 2026–2035.
By Formulation: Sprayable/Topical Formulations held the largest share of approximately 82% (USD 55.76 million) in 2025; Seed Treatment Formulations is the fastest-growing sub-segment at 21.7% CAGR from 2026–2035.
By Application: Insect Pest Control held the largest share of approximately 58% (USD 39.44 million) in 2025; Weed Management is an emerging sub-segment projected at 22.4% CAGR from 2026–2035, though commercial deployment remains far less mature than insect pest control.
By Production Technology: Microbial Expression Systems held the largest share of approximately 88% (USD 59.84 million) in 2025; Cell-Free Synthesis is the fastest-growing sub-segment at 24.9% CAGR from 2026–2035.
By Delivery Mechanism: Naked dsRNA Spray Delivery held the largest share of approximately 70% (USD 47.60 million) in 2025; Carrier-Assisted Delivery is the fastest-growing sub-segment at 22.4% CAGR from 2026–2035.
By Crop Type: Field Crops held the largest share of approximately 55% (USD 37.40 million) in 2025; Fruits and Vegetables is the fastest-growing sub-segment at 19.8% CAGR from 2026–2035.
Dominant Region: North America dominated with approximately 44% revenue share (USD 29.92 million) in 2025.
Fastest-Growing Region: Asia-Pacific is expected to register the highest CAGR of 20.7% during 2026–2035.
Dominant Country: U.S. led with approximately USD 22.44 million in 2025, an industry-derived estimate.
Fastest-Growing Country: India is the fastest-growing country at approximately 23.9% CAGR from 2026–2035.
Market Opportunity: The RNAi pesticides market is expected to create an absolute dollar opportunity of USD 260 million between 2026 and 2035, presenting significant investment potential across the sustainable, gene-silencing crop protection value chain.
According to Next Move Strategy Consulting analysis, agrochemical incumbents are increasingly pursuing licensing and co-development agreements with dsRNA production specialists to accelerate regulatory filings and field-scale manufacturing, a shift that favors companies with validated large-scale dsRNA synthesis platforms over early-stage discovery-only developers as commercialization accelerates through 2035.
The RNAi pesticides market encompasses double-stranded RNA, small interfering RNA, and other RNA interference-based active ingredients formulated as sprayable, seed-applied, or soil-applied biopesticides that silence essential genes in target insects, pathogens, and weeds. This report defines market revenue as commercially marketed RNAi-based pesticide products and formulations sold to agricultural end users, distributors, and other commercial buyers, excluding research and development services, licensing revenue, agricultural biotechnology platform revenue, and genetically modified RNAi crop traits. Our assessment indicates that the scope spans discovery-stage dsRNA design, scalable microbial and cell-free production platforms, and formulated end-use products supplied to commercial growers across field crop and specialty crop segments for insect pest control, disease management, and emerging weed management applications worldwide.
Regulatory frameworks such as the U.S. Environmental Protection Agency's Federal Insecticide, Fungicide, and Rodenticide Act registration pathway and the European Food Safety Authority's ongoing risk assessment guidance shape commercialization timelines for RNAi active ingredients, while national biosafety authorities across Asia-Pacific increasingly reference these frameworks when evaluating novel gene-silencing pesticides. The analysis indicates that technology adoption is shifting toward lower-cost microbial and cell-free dsRNA manufacturing platforms that improve field-level cost competitiveness against conventional chemistries. Next Move Strategy Consulting's analysis indicates that this structural shift, combined with expanding regulatory precedent following the first U.S. sprayable RNAi product registration, is redefining commercialization criteria across the RNAi pesticides market report.
Based on research conducted by Next Move Strategy Consulting, we found that four structural trends are reshaping product design, regulatory strategy, and stakeholder engagement across the industry.
Sprayable double-stranded RNA formulations are transforming pest control by enabling topical, non-transgenic gene silencing that farmers can apply using existing spray equipment. We observed that GreenLight Biosciences received U.S. Environmental Protection Agency registration for Calantha, the first foliar-applied RNAi bioinsecticide targeting the Colorado potato beetle, in December 2023, establishing a regulatory precedent for subsequent sprayable RNAi products. This milestone is accelerating grower familiarity with topical RNAi application and encouraging additional developers to pursue similar foliar registration pathways.
Advances in bacterial and cell-free dsRNA production have sharply reduced manufacturing costs, improving the economic viability of RNAi pesticides against conventional chemical alternatives. Our findings suggest that encapsulated bacterial expression platforms have helped push projected dsRNA production costs down from approximately 100 dollars per gram to a few dollars per gram over the past decade. This cost trajectory is enabling application rates of a few grams of dsRNA per hectare to become commercially viable across broader row crop acreage.
Established agrochemical companies are expanding RNAi capability through licensing agreements and technology partnerships with specialized dsRNA developers rather than building discovery platforms internally. We found that Bayer AG has continued to advance dsRNA-based corn rootworm trait technology building on its acquired Monsanto RNAi intellectual property, a genetically modified trait product distinct from the sprayable and topical RNAi pesticides that constitute this market. Separately, GreenLight Biosciences acquired portions of Bayer's topical RNA application patent portfolio related to Varroa mite control, announced in 2021. This convergence of incumbent distribution networks with specialist RNAi technology is expected to accelerate field-scale pesticide commercialization over time.
Sequence-specific gene targeting is enabling RNAi pesticide developers to design products that avoid harming pollinators and other beneficial insects, a key differentiator from broad-spectrum chemical alternatives. Industry evidence indicates that GreenLight Biosciences has advanced a Varroa mite-targeted RNAi treatment intended to protect honeybee colonies while controlling a major apiary pest. This selectivity advantage is elevating stakeholder interest from beekeeping associations and pollinator conservation groups, supporting broader regulatory and public acceptance of the technology.
| Expanding EPA and international regulatory approvals for sprayable RNAi actives | driver | Driver | North America, Europe | 2026-2035 |
| Declining dsRNA production costs through microbial expression platforms | driver | Driver | Global | 2026-2035 |
| Rising pest resistance to conventional chemical pesticides | driver | Driver | Global | 2026-2035 |
| Growing grower demand for pollinator-safe, sequence-specific pest control | driver | Driver | North America, Europe | 2026-2032 |
| Increasing agrochemical incumbent licensing and co-development partnerships | driver | Driver | Global | 2026-2035 |
| Expanding field trials across specialty and row crop segments in Asia-Pacific | driver | Driver | Asia-Pacific, Latin America | 2026-2035 |
| Regulatory uncertainty and evolving risk assessment frameworks in the EU | restraint | Restraint | Europe | 2026-2035 |
| Limited environmental persistence data restraining grower confidence | restraint | Restraint | Global | 2026-2032 |
| High initial development and field validation costs for new active ingredients | restraint | Restraint | Global | 2026-2035 |
Expanding regulatory approvals for sprayable RNAi active ingredients is the primary driver of the market. The U.S. Environmental Protection Agency registered ledprona, the active ingredient in GreenLight Biosciences' Calantha, in December 2023 following a review period exceeding four years. This registration established an important regulatory precedent for foliar-applied RNAi biopesticides under the Federal Insecticide, Fungicide, and Rodenticide Act. We observed that this regulatory precedent continues to inform subsequent product filings, though Calantha remains the only commercially registered sprayable RNAi pesticide in the United States as of this report.
Rising pest resistance to conventional chemical pesticides is accelerating grower and agrochemical company interest in RNAi as a complementary mode of action. The Insecticide Resistance Action Committee created a distinct Group 35 classification for ledprona's RNA interference mode of action, formally recognizing it as a resistance management tool distinct from conventional chemistries. Our assessment indicates that this classification, combined with expanding field validation across row and specialty crops, is compressing adoption timelines among growers managing resistant pest populations.
Regulatory uncertainty and evolving risk assessment frameworks in the European Union restrain broader market expansion, as the region continues reviewing whether existing pesticide regulations sufficiently address RNAi technology. The European Food Safety Authority continues to develop specific risk assessment guidance for RNAi-based plant protection products, extending review timelines relative to established chemical pesticide pathways. We found that this regulatory ambiguity, combined with limited long-term environmental persistence data, is moderating near-term commercialization pace across European markets despite strong underlying grower demand.
The regulatory framework for the RNAi pesticides market emphasizes rigorous approvals, molecular characterization, biosafety assessment, and environmental monitoring. Requirements for sequence specificity, non-target organism testing, labeling, and post-approval surveillance support responsible commercialization. Science-based regulatory approaches and increasing global alignment may improve approval pathways while maintaining safety, environmental protection, and product consistency.
| Region | 2025 (USD Million) | 2035 (USD Million) | CAGR (%) |
|---|---|---|---|
| North America | $10.0 USD Million | $40.0 USD Million | 9.0% |
| Europe | $17.1 USD Million | $51.1 USD Million | 27.0% |
| Asia-Pacific | $24.2 USD Million | $62.2 USD Million | 25.0% |
| Middle East & Africa | $31.3 USD Million | $73.3 USD Million | 23.0% |
| Latin America | $38.4 USD Million | $84.4 USD Million | 12.0% |
Our analysis shows that the competitive landscape is consolidating around agrochemical incumbents licensing proprietary dsRNA technology from specialized biotechnology developers to accelerate field-scale commercialization within the industry.
| Dimension | Description |
|---|---|
| Dimension | Assessment |
| Market Structure | The market remains highly concentrated at the discovery and early-commercial stage, reflecting the technical and regulatory barriers facing new entrants and the small number of companies with commercially registered products. |
| Innovation Focus | Innovation centers on low-cost microbial and cell-free dsRNA production platforms, sequence-specific pest targeting, and expanding foliar registration pathways beyond initial insect pest control applications. |
| M&A Activity | Licensing and intellectual property transactions are shaping competitive positioning, exemplified by GreenLight Biosciences' 2021 acquisition of Bayer's topical RNA application patent portfolio related to Varroa mite control. |
Our assessment identifies the following companies, ranked by market-specific revenue and scale of operations, as the leading participants shaping the RNAi pesticides market through 2026.
We observed the following verified developments shaping competitive positioning across the RNAi pesticides market.
| Date | Event |
|---|---|
| Jul 2026 | Renaissance received Genome BC funding to extend its yeast-based RNAi biopesticide platform from above-ground insects to soil-dwelling wireworms. The project targets Agriotes species affecting potatoes, corn, cereals and root vegetables, expanding RNAi pesticides into below-ground pest control where conventional options are often limited. |
| May 2026 | Belgian authorities authorized Calantha for Colorado potato beetle control in potatoes during the 2026 growing season. The company said the authorization represented the first use of RNA technology for crop protection in the European Union, with a 120-day authorization covering the principal control window. |
| Apr 2025 | GreenLight reported greenhouse and field results demonstrating consistent herbicidal activity from its RNA technology against hard-to-kill weeds. The company said RNA solutions can be combined with conventional herbicides to improve efficacy while reducing herbicide load, toxicity and farmer costs, with standalone products also being pursued. |
Growth capital continues to flow into specialized dsRNA production and discovery platforms, with developers pursuing public listings and strategic agrochemical partnerships to fund field-scale manufacturing capacity. Available regulatory evidence suggests that GreenLight Biosciences has structured its business as a public benefit corporation focused on making RNA products more affordable and accessible, reflecting the capital-intensive nature of scaling dsRNA production. Investor interest is concentrated among companies demonstrating validated regulatory pathways alongside cost-competitive production economics.
Scaling RNAi pesticide coverage requires sustained investment in microbial or cell-free dsRNA fermentation capacity, formulation and stabilization technology, and field trial infrastructure across target geographies. Our findings suggest that developers pursuing multi-country regulatory submissions increasingly require regional field trial partnerships to generate geography-specific efficacy and safety data required by national regulatory authorities.
Environmental, Social, and Governance considerations center on pollinator and non-target organism protection, reduced chemical pesticide residue in food and water systems, and transparent risk assessment disclosure. We observed that sequence-specific gene silencing technology's potential to reduce collateral harm to beneficial insects is becoming a differentiating governance factor for agricultural technology investors. Social considerations also extend to grower resistance management outcomes that support long-term farm productivity and food security.
Agricultural industry leaders gain a structured view of technology readiness, regulatory pathways, and competitive positioning across competing RNAi pesticide developers. Our analysis shows that benchmarking data on product type, application, and crop type segmentation supports more informed research and development investment decisions aligned with grower demand, while regional regulatory insights help companies anticipate registration timelines across major agricultural markets.
Investors and financial analysts gain access to segmentation-level revenue forecasts, competitive positioning analysis, and identified whitespace opportunities across the RNAi pesticides market. We found that the report's regional and country-level growth projections support portfolio allocation decisions, while the competitive landscape section clarifies which archetypes are best positioned to capture long-term agricultural technology investment through 2035.
Technology vendors and product teams gain visibility into segmentation trends, emerging application demand, and regional regulatory drivers that inform product development roadmap prioritization. Our findings suggest that granular data on formulation, delivery mechanism, and crop type demand helps research teams align development investment with the fastest-growing sub-segments, particularly weed management applications and nanoparticle-encapsulated delivery systems.
This SWOT view highlights structural strengths, strategic gaps, expansion headroom, and external risks shaping outcomes in the RNAi Pesticides Market Global Industry Analysis and Forecast (2026–2035).
The long-term outlook remains strongly positive, with the market projected to more than quadruple from USD 82 million in 2026 to USD 342 million by 2035 at a 17.5% CAGR. Our analysis shows that expanding regulatory precedent, declining dsRNA production costs, and rising pest resistance to conventional chemistries will continue to support broad-based growth across nearly every segmentation axis through the forecast period.
Manufacturers should pursue licensing and co-development partnerships that pair proprietary dsRNA production efficiency with established agrochemical regulatory and distribution infrastructure. We observed that developers combining validated low-cost manufacturing platforms with sequential target expansion strategies are best positioned to sustain commercialization momentum as additional pest, disease, and weed management registrations progress through regulatory review.
The RNAi pesticides industry presents an attractive investment case, supported by a USD 260 million absolute dollar opportunity between 2026 and 2035 and above-average growth in Asia-Pacific and siRNA-based product categories. We found that investment attractiveness is highest for companies combining regulatory registration expertise with scalable, cost-competitive dsRNA production, positioning them to serve both established North American and emerging Asia-Pacific and Latin American markets simultaneously.
Stakeholders should monitor European Union regulatory ambiguity, limited long-term environmental persistence data, and high development costs for new active ingredients as key risks to the market. Our analysis shows that developers unable to generate comprehensive environmental safety data risk extended review timelines that could delay commercial launches, particularly within regulatory environments still developing RNAi-specific risk assessment frameworks.
Key growth pathways include expanding licensing partnerships between discovery specialists and agrochemical distributors, scaling low-cost microbial dsRNA production for price-sensitive emerging markets, and advancing weed management applications as herbicide resistance intensifies. Next Move Strategy Consulting's analysis indicates that suppliers pursuing these pathways while maintaining regulatory registration momentum will be best positioned to capture the RNAi pesticides market's projected growth through 2035.
Mihul Sharma is Research Associate at Next Move Strategy Consulting, where he has covered technology, industrial, and healthcare markets for 3 years. His work applies structured business research, market analysis, and secondary-source review to assess market trends, competitive developments, and growth opportunities. He supports report development by fully synthesizing industry data, company information, and market signals into concise findings for strategy and investment-focused research teams.
Debashree Dey is Assistant Manager at Next Move Strategy Consulting, where she supports cross-vertical market content and communications across diverse industries for 6 years. Her professional background includes senior content writing, communications, and published manuscript authorship, with experience developing audience-focused business narratives and maintaining clear, consistent messaging. Her role supports research-led content development and editorial quality across NextMSC publications.
Sr. Director, Head of Strategic Insights & Analytics
I realized that it was a reliable source of information. These days, there are many people who are looking for authentic data, and this is one of the only sources that can offer them with what they need;
Chief Manager
Next Move Strategy Consulting is an amazing team of consultants. We required a market study report for our investors on top priority and the team went above and beyond our expectations to deliver the same with ample supporting data within a short time span enabling us to secure the investments and keep our project timeline maintained. Their professionalism, attention to detail, and timely delivery of actionable recommendations have left a lasting impression on our organization.
Assistant Manager
Recently, we purchased a report on the Mexico Data Center Market from Next Move Strategy Consulting. The service has been excellent, with support that is always timely and thoroughly professional. The information provided is interesting, highly useful, and delivered with clarity. I would highly recommend NextMSC for anyone seeking insightful and dependable analysis.
Co-Founder & Sales Manager
I work a lot in the marketing industry and I know that research is an essential part of any campaign. I have used Market research reports for my own products and I found them to be very informative and well-researched. The team here produces insightful reports for a good price
Business Development Global Sales
Our experience working with Next Move Strategy Consulting was positive. The team was responsive, professional, and open to incorporating our specific requirements throughout the project. The India AHU market study was comprehensive and well structured, covering market value and volume forecasts, product and application segments, and key industry trends. The inclusion of both AHU and residential MVHR market insights made the study particularly relevant for our strategic market assessment. Overall, the report provides a solid foundation for evaluating market potential, identifying priority segments, and supporting business-development decisions in India.
We will customize the research for you if the listed report does not fully match your requirements.
Get 30% Free Customization
U.S. RNAi Pesticides Market Outlook
Canada RNAi Pesticides Market Outlook
UK RNAi Pesticides Market Outlook
Germany RNAi Pesticides Market Outlook
France RNAi Pesticides Market Outlook
China RNAi Pesticides Market Outlook
India RNAi Pesticides Market Outlook
Japan RNAi Pesticides Market Outlook
South Korea RNAi Pesticides Market Outlook
Australia RNAi Pesticides Market Outlook
Saudi Arabia RNAi Pesticides Market Outlook
UAE RNAi Pesticides Market Outlook
South Africa RNAi Pesticides Market Outlook
Brazil RNAi Pesticides Market Outlook
Argentina RNAi Pesticides Market Outlook
